Evidence map›Paper›PMID 39501009›Full record

Trial reportHypertension research : official journal of the Japanese Society of Hypertension2025

Effectiveness of the intelligent hypertension excellence centers (iHEC) therapy model in the blood pressure management of older hypertensive patients: a randomized controlled trial.

Yuqin Jiang, Lijun Zheng, Yunhe Zhang, Zhen Fan, Jianshu Guo, Junling Yang, Peng Liu, Ping Zhong, Dili Xie

Abstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Hypertension research : official journal of the Japanese Society of Hypertension, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Yuqin Jiang *Medical School of University of Electronic Science and Technology of China, Chengdu, China.
Lijun Zheng *Department of Geriatric Cardiology, Sichuan Provincial People's Hospital, school of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Yunhe ZhangDepartment of Geriatric Cardiology, Sichuan Provincial People's Hospital, school of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Zhen FanDepartment of Geriatric Cardiology, Sichuan Provincial People's Hospital, school of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Jianshu GuoDepartment of Geriatric Cardiology, Sichuan Provincial People's Hospital, school of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Junling YangDepartment of Medical Library, Sichuan Provincial People's Hospital, school of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Peng LiuDepartment of Geriatric Cardiology, Sichuan Provincial People's Hospital, school of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Ping ZhongDepartment of Geriatric Cardiology, Sichuan Provincial People's Hospital, school of Medicine, University of Electronic Science and Technology of China, Chengdu, China. aoaol@126.com.
Dili XieDepartment of Geriatric Cardiology, Sichuan Provincial People's Hospital, school of Medicine, University of Electronic Science and Technology of China, Chengdu, China. w18980802108@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intelligent hypertension excellence centers (iHEC) may improve blood pressure (BP) management in older hypertensive patients. However, this has not yet been rigorously evaluated, so we conducted a prospective randomized open-label clinical trial to verify this hypothesis. Older patients with hypertension were recruited between January and June 2022. The control group received conventional treatment and visited doctors in clinic. The intervention group received the iHEC therapy model, including remote BP management, online consultation, and follow-up services with support from the internet. Both groups received 12 months follow-up. Finally, 540 older patients with hypertension participated in the study; of these, 517 completed the follow-up. The average age was 71.4 ± 3.7years, 81 patients with frailty (15.7%). When follow-up was terminated, the SBP of the intervention group was 4.2 mmHg lower than that of the control group (95% CI, 2.0 to 6.4, P < 0.001), and the overall BP control rate in the intervention group was higher than that in the control group (60.2% vs. 48.1%, P < 0.05). During follow-up, the new-onset rate of excessive BP lowering in the intervention group was lower than that in the control group (3.8% vs. 9.0%, P < 0.05). Patients with a median age or above and high school education or above had higher numbers of online consultations and home BP measurements (P < 0.05).Our study confirmed those who received the iHEC therapy model achieved better BP reduction, higher rates of BP control, and alleviated the risk of excessive BP reduction.

Indexed as

Blood PressureHypertensionAgedAntihypertensive AgentsFemaleHumansMaleProspective StudiesTelemedicineTreatment OutcomeAntihypertensive Agentsblood pressure managementhypertensionintelligentolder

Identifiers

PMID39501009
PMCPMC11700847

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.